How One Molecule Drives Oral Cancer Spread: TMU Researchers Uncover a Key Metastatic Pathway

New Findings reveal how the inflammation-related molecule CXCL8 enables oral cancer cells to invade surrounding tissues and spread to lymph nodes-opening new possibilities for predicting and potentially preventing metastasis.

A tumor becomes most dangerous not simply when it grows, but when its cells learn how to escape.

For patients with oral cancer, metastasis is one of the greatest barriers to successful treatment. Once cancer cells spread beyond the original tumor, particularly to nearby lymph nodes, the disease becomes more difficult to control and survival outcomes decline significantly.

Researchers at Taipei Medical University (TMU) have now uncovered an important molecular mechanism that may help explain how oral cancer cells acquire this ability to move and invade.

Led by Associate Professor Ju-Fang Liu, Associate Professor Ying-Sui Sun, and Associate Professor Kuan-Chou Lin from TMU’s College of Oral Medicine, in collaboration with researchers from China Medical University, the team identified the molecule CXCL8 as a key driver of oral cancer metastasis.

Their findings reveal a chain reaction inside cancer cells that increases their mobility, helps them break through surrounding tissues, and promotes their spread to lymph nodes. The discovery could support the future development of new biomarkers and targeted strategies designed specifically to prevent oral cancer from spreading.

A Critical Clue: The Role of CXCL8

Through comprehensive data analysis and laboratory experiments, the team identified CXCL8 as a central player in oral cancer progression. CXCL8 is typically involved in inflammation, helping the body respond to injury or infection. In cancer, however, this molecule can be repurposed to support tumor growth and spread.

The study found significantly higher levels of CXCL8 in oral cancer tissues, with elevated expression strongly associated with poorer patient survival. In other words, higher CXCL8 levels may indicate a more aggressive disease.

Turning Cancer Cells into “Movers”

One of the study’s most striking findings was CXCL8’s ability to enhance cancer cell mobility.

Through a series of experiments, the researchers demonstrated that cancer cells with higher CXCL8 levels move more rapidly and exhibit stronger invasive behavior. When additional CXCL8 was introduced, the cells became even more mobile, suggesting a direct cause-and-effect relationship.

CXCL8 therefore acts like a molecular “switch,” enabling oral cancer cells to migrate and invade surrounding tissues more efficiently.

Breaking Barriers: The Role of MMP1

To metastasize, cancer cells must break through the tissues surrounding the tumor. The study found that CXCL8 promotes this process by increasing the production of another molecule called MMP1.

MMP1 functions like a molecular tool that breaks down the structural barriers surrounding cells, allowing cancer cells to invade nearby tissues and eventually spread to distant organs. Importantly, when MMP1 was suppressed, the ability of cancer cells to migrate was significantly reduced.

These findings highlight a clear link: CXCL8 enhances cancer spread by activating MMP1.

Mapping the Signaling Pathway

The researchers further uncovered the internal signaling process that connects CXCL8 to cancer metastasis.

They identified a key pathway:
CXCL8 → CXCR1/2 receptors → JAK1/STAT3 signaling → MMP1 activation

This signaling cascade functions like a chain reaction inside cancer cells, ultimately increasing their mobility and invasiveness. When individual components of the pathway were blocked, cancer cell movement was significantly reduced, confirming its critical role in metastasis.

From Laboratory to Living Systems

To validate these findings, the team conducted animal experiments using a mouse model of oral cancer. The results showed that blocking CXCL8-related signaling effectively reduced cancer spread to nearby lymph nodes.

Interestingly, while tumor size itself was not significantly affected, the ability of the cancer to spread was clearly suppressed.

This distinction is crucial, as metastasis—rather than the primary tumor—is often the main cause of cancer-related mortality.

A New Direction for Targeted Therapy

This study provides compelling evidence that CXCL8 plays a central role in driving oral cancer metastasis. As a result, it holds strong potential in two key areas:

• Biomarker: CXCL8 could help predict disease progression and patient prognosis
• Therapeutic target: Blocking this pathway may offer a new strategy to prevent cancer spread

Notably, drugs targeting components of this signaling pathway are already under investigation in other cancers, suggesting promising opportunities for future clinical application in oral cancer treatment.

Advancing Global Impact Through TMU Research

By revealing how an inflammation-related molecule can drive cancer metastasis, this research marks an important step forward in understanding oral cancer biology. The findings not only deepen scientific knowledge but also open new possibilities for developing more precise and effective treatments.

Through this work, Taipei Medical University continues to advance translational research and contributing to global efforts in improving cancer care.

---

Look for More Information

Original Article: CXCL8 Drives MMP1 Upregulation and Promotes Metastatic Progression in Oral Cancer Through CXCR1/2-Mediated JAK1/STAT3 Activation

Keywords: Oral squamous cell carcinoma, CXCL8, Metastasis, MMP1, JAK1/STAT3 pathway

Author Profiles (From Left to Right): 

• Ju-Fang Liu, Associate Professor, School of Oral Hygiene, College of Oral Medicine
• Ying-Sui Sun, Associate Professor, School of Dental Technology, College of Oral Medicine
• Kuan-Chou Lin, Associate Professor, School of Dentistry, College of Oral Medicine